뉴스벤징가
Regeneron Secures FDA Approval For Ultra-Rare Bone Disorder Drug
· 발표
기사 요약
Regeneron Pharmaceuticals secured FDA approval for Pasatru, a novel monthly infusion therapy proven to reduce lesions in FOP patients.
기사 원문에서 발췌했어요.뉴스 본문을 불러오고 있어요.
Regeneron Pharmaceuticals secured FDA approval for Pasatru, a novel monthly infusion therapy proven to reduce lesions in FOP patients.
기사 원문에서 발췌했어요.
댓글 —
댓글을 불러오고 있어요…